Objectives Eosinophilic bronchiectasis is defined by a blood eosinophil count (BEC) ≥300 cells/µL, but blood eosinophils imperfectly reflect airway eosinophilic inflammation. Here, we investigated the ...
DogsBestLife.com on MSN
How to read your dog’s blood work like a veterinarian: Simple steps
Learn how to understand dog blood work with this comprehensive guide. Decode CBC, chemistry panels, liver, and kidney values.
Sleep disorder and elevated eosinophil count have emerged as new adverse events associated with nemolizumab use. Nemolizumab has a generally favorable postmarketing safety profile, with less serious ...
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit (ICU), lower eosinophil counts are associated with increased in-hospital ...
A 30-year-old Chinese male diagnosed with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy presented with cerebrospinal fluid (CSF) eosinophilia. Magnetic resonance imaging (MRI) ...
Please provide your email address to receive an email when new articles are posted on . Among adults with moderate to severe asthma receiving rademikibart, those with a high eosinophil count plus high ...
In the EXHALE-4 study, dexpramipexole met the primary endpoint with statistically significant improvement in lung function compared with placebo Dexpramipexole demonstrated statistically significant ...
Elevated absolute eosinophil counts and absolute basophil counts (ABC) are associated with reduced overall survival in essential thrombocythemia. In polycythemia vera, higher ABC correlates with ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The U.S. Food and Drug Administration (FDA) has approved Nucala ...
May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...
Treatment with Nucala, an interleukin-5 antagonist monoclonal antibody, significantly reduced exacerbations leading to hospitalizations and emergency department visits. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results